Nanolipogel Vehicles for Controlled Delivery of Different Pharmaceutical Agents
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 6 of these applications claim priority to application PCT/US2013/036487, filed Apr 12, 2013. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,610,250 | Nanolipogel Vehicles for Controlled Delivery of Different Pharmaceutical Agents In force · High confidence | Yale University | In force | High confidence | ||
| US 10,034,917 | Nanoparticle-Mediated Delivery of Cytokines for Maintenance of the Regulatory T Cell Phenotype In force · High confidence | Yale University | In force | High confidence | ||
| US 10,500,157 | Nanoparticle-Mediated Delivery of Cytokines for Maintenance of the Regulatory T Cell Phenotype In force · High confidence | Yale University | In force | High confidence | ||
| US 10,603,276 | Nanolipogel Vehicles for Controlled Delivery of Different Pharmaceutical Agents In force · High confidence | Yale University | In force | High confidence | ||
| US 11,173,119 | Nanolipogel Vehicles For Controlled Delivery of Different Pharmaceutical Agents In force · High confidence | Yale University | In force | High confidence | ||
| US 12,156,939 | Nanolipogel Vehicles for Controlled Delivery of Different Pharmaceutical Agents In force · Medium confidence | Yale University | In force | Medium confidence |
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.